These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7474915)

  • 1. Apolipoprotein E and amyloidogenesis.
    Castaño EM; Prelli FC; Frangione B
    Lab Invest; 1995 Oct; 73(4):457-60. PubMed ID: 7474915
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of apolipoprotein E with murine amyloid A protein amyloid.
    Kindy MS; King AR; Perry G; de Beer MC; de Beer FC
    Lab Invest; 1995 Oct; 73(4):469-75. PubMed ID: 7474917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E and Alzheimer's.
    van Bockxmeer FM
    Nature; 1995 May; 375(6529):285. PubMed ID: 7753191
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunotargeting of apolipoprotein E in amyloid: an initial trial in mice.
    Yamada T; Someya T; Fujita S
    Ann Clin Lab Sci; 2009; 39(2):134-7. PubMed ID: 19429798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E and cognitive performance.
    Raber J; Wong D; Yu GQ; Buttini M; Mahley RW; Pitas RE; Mucke L
    Nature; 2000 Mar; 404(6776):352-4. PubMed ID: 10746713
    [No Abstract]   [Full Text] [Related]  

  • 6. Apolipoprotein E is associated with islet amyloid and other amyloidoses: implications for Alzheimer's disease.
    Chargé SB; Esiri MM; Bethune CA; Hansen BC; Clark A
    J Pathol; 1996 Aug; 179(4):443-7. PubMed ID: 8869295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical evidence for the biphasic development of experimental amyloidosis.
    Sipe JD; McAdam KP; Uchino F
    Lab Invest; 1978 Jan; 38(1):110-4. PubMed ID: 621923
    [No Abstract]   [Full Text] [Related]  

  • 8. Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner.
    Thal DR; Capetillo-Zarate E; Schultz C; Rüb U; Saido TC; Yamaguchi H; Haass C; Griffin WS; Del Tredici K; Braak H; Ghebremedhin E
    Acta Neuropathol; 2005 Nov; 110(5):459-71. PubMed ID: 16195918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunomorphologic study of the early stages of amyloidogenesis].
    Kapinus LN
    Biull Eksp Biol Med; 1978 Feb; 85(2):232-4. PubMed ID: 343835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Casein-induced murine amyloidosis: amyloidogenesis in vitro by monolayer spleen explants of casein-injected mice.
    Baumal R; Sklar S; Wilson B; Laskov R
    Lab Invest; 1978 Dec; 39(6):632-9. PubMed ID: 368432
    [No Abstract]   [Full Text] [Related]  

  • 11. Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice.
    Hoshii Y; Kawano H; Cui D; Takeda T; Gondo T; Takahashi M; Kogishi K; Higuchi K; Ishihara T
    Am J Pathol; 1997 Oct; 151(4):911-7. PubMed ID: 9327723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alzheimer's disease and apolipoprotein E].
    Yamaguchi H
    No To Shinkei; 1996 Nov; 48(11):981-90. PubMed ID: 8951889
    [No Abstract]   [Full Text] [Related]  

  • 13. Human amyloidosis, Alzheimer disease and related disorders.
    Castaño EM; Frangione B
    Lab Invest; 1988 Feb; 58(2):122-32. PubMed ID: 3276958
    [No Abstract]   [Full Text] [Related]  

  • 14. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
    Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
    J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical localization of apolipoprotein E in renal amyloidosis.
    Taniguchi Y; Yorioka N; Yamashita K; Oda H; Nie LF; Ye Yeu XF; Okushin S; Nishida Y; Kushihata S; Yamakido M
    Hiroshima J Med Sci; 1996 Mar; 45(1):11-4. PubMed ID: 8984100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human brain pericytes as a model system to study the pathogenesis of cerebrovascular amyloidosis in Alzheimer's disease.
    Verbeek MM; Otte-Höller I; Ruiter DJ; de Waal RM
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):37-46. PubMed ID: 10099838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of perlecan gene expression precedes amyloid formation during experimental murine AA amyloidogenesis.
    Ailles L; Kisilevsky R; Young ID
    Lab Invest; 1993 Oct; 69(4):443-8. PubMed ID: 8231112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments.
    Ma J; Yee A; Brewer HB; Das S; Potter H
    Nature; 1994 Nov; 372(6501):92-4. PubMed ID: 7969426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E, amyloid, and Alzheimer disease.
    Bales KR; Dodart JC; DeMattos RB; Holtzman DM; Paul SM
    Mol Interv; 2002 Oct; 2(6):363-75, 339. PubMed ID: 14993413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E and alpha 1-antichymotrypsin in dialysis-related amyloidosis.
    Gejyo F; Kimura H; Suzuki S; Miyazaki R; Naiki H; Nakakuki K
    Kidney Int Suppl; 1997 Nov; 62():S75-8. PubMed ID: 9350687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.